World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
25643
World Ranking
15590
National Ranking
7854

Overview

Mizuki Nishino is affiliated with Harvard University in the United States and has a research focus primarily in the field of Medicine, with notable contributions to Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, and Cancer Research.

The scope of their research covers several main topics, including:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research

Among recent notable papers authored or co-authored by Mizuki Nishino are:

  • Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels, 2022, JAMA Oncology
  • Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status, 2021, Journal of Thoracic Oncology
  • Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC, 2020, Clinical Cancer Research
  • Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC, 2023, Cancer Discovery
  • Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer, 2020, Clinical Cancer Research

Frequent co-authors collaborating with Mizuki Nishino include:

  • Mark M. Awad
  • Hiroto Hatabu
  • Biagio Ricciuti
  • Lynette M. Sholl
  • Joao V. Alessi

The researcher has published extensively in key scientific venues, with frequent publications appearing in:

  • Journal of Thoracic Oncology
  • Radiology
  • Journal of Clinical Oncology
  • JCO Precision Oncology
  • American Journal of Respiratory and Critical Care Medicine

Mizuki Nishino has contributed to book publications, including a work published by Springer Nature titled Therapy Response Imaging in Oncology in 2020.

Best Publications

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Monitoring immune-checkpoint blockade: response evaluation and biomarker development

    Mizuki Nishino;Nikhil H. Ramaiya;Hiroto Hatabu;F. Stephen Hodi

  • Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis

    Mizuki Nishino;Anita Giobbie-Hurder;Hiroto Hatabu;Nikhil H. Ramaiya

  • Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities

    George R. Washko;Gary M. Hunninghake;Isis E. Fernandez;Mizuki Nishino

  • Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements

    Mizuki Nishino;Anita Giobbie-Hurder;Maria Gargano;Margaret Suda

  • A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

    Zhao Chen;Katherine Cheng;Zandra Walton;Yuchuan Wang

  • PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

    Mizuki Nishino;Nikhil H. Ramaiya;Mark M. Awad;Lynette M. Sholl

  • Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know

    Mizuki Nishino;Jyothi P Jagannathan;Nikhil H Ramaiya;Annick D Van den Abbeele

  • MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities

    Gary M. Hunninghake;Hiroto Hatabu;Yuka Okajima;Wei Gao

  • Institutional implementation of clinical tumor profiling on an unselected cancer population

    Lynette M. Sholl;Khanh Do;Priyanka Shivdasani;Ethan Cerami

  • Association Between Interstitial Lung Abnormalities and All-Cause Mortality

    Rachel K. Putman;Hiroto Hatabu;Tetsuro Araki;Gunnar Gudmundsson

  • Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.

    Stephanie Cardarella;Atsuko Ogino;Mizuki Nishino;Mohit Butaney

  • Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy

    Nishino M;Sholl Lm;Hodi Fs;Hatabu H

  • Primary Retroperitoneal Neoplasms: CT and MR Imaging Findings with Anatomic and Pathologic Diagnostic Clues

    Mizuki Nishino;Katsumi Hayakawa;Manabu Minami;Akira Yamamoto

  • Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions

    Geoffrey R. Oxnard;Geoffrey R. Oxnard;Peter C. Lo;Mizuki Nishino;Suzanne E. Dahlberg

  • The thymus: a comprehensive review.

    Mizuki Nishino;Simon K. Ashiku;Olivier N. Kocher;Robert L. Thurer

  • Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy

    F. Stephen Hodi;Marcus Ballinger;Benjamin Lyons;Jean Charles Soria

  • Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications.

    Biagio Ricciuti;Suzanne E Dahlberg;Anika Adeni;Lynette M Sholl

  • Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.

    Tetsuro Araki;Rachel K. Putman;Hiroto Hatabu;Wei Gao;Wei Gao

  • Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.

    E.J. Aguilar;B. Ricciuti;J.F. Gainor;K.L. Kehl

Frequent Co-Authors

Hiroto Hatabu
Hiroto Hatabu Brigham and Women's Hospital
Mark M. Awad
Mark M. Awad Harvard University
Lynette M. Sholl
Lynette M. Sholl Brigham and Women's Hospital
Pasi A. Jänne
Pasi A. Jänne Harvard University
Bruce E. Johnson
Bruce E. Johnson Harvard University
George R. Washko
George R. Washko Brigham and Women's Hospital
F. Stephen Hodi
F. Stephen Hodi Harvard University
Josée Dupuis
Josée Dupuis McGill University
George T. O'Connor
George T. O'Connor Boston University
Andrew D. Cherniack
Andrew D. Cherniack Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare education is a smart option for prospective medical students or those interested in related fields. Accredited online programs offer flexibility and accessibility for those balancing work or other commitments. For instance, the best medical billing and coding schools online provide training for in-demand administrative roles in healthcare and often offer financial aid.

Nursing remains a popular career pathway, and you can get started without standardized exam barriers. Programs such as lpn school without teas test let aspiring nurses begin their journey more easily. If you aim to move into leadership or administrative roles, earning a degree from an online healthcare administration degree program can accelerate your progress.

For registered nurses looking to advance, options like adn to fnp bridge programs offer a streamlined pathway to advanced practice and higher earning potential. With so many online opportunities, there’s a flexible route to fit your career goals within healthcare.

Best Scientists Citing Mizuki Nishino

Trending Scientists

Recently Published Articles